The Natural Products Association today, in a Request for Information (RFI) response, submitted its proposal to regulate cannabidiol (CBD) to the United States House and Senate.
NPA provided official testimony for the record about the Food and Drug Administration’s (FDA) glaring lack of progress on any meaningful path towards regulation of CBD, an ingredient in products sold nearly everywhere in the United States.
The NPA Awards salute industry pioneers and leaders for their accomplishments in science, environmental issues, advocacy, social responsibility, and the industry at large.
